Top
FBXL2 has not been detected as a mutational cancer driver

FBXL2
Ensembl id ENSG00000153558
Mutated samples
Coding Sequence 47 (0.7%)
Protein Affecting 24 (0.4%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all FBXL2 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Cutaneous melanoma No 9 8 2.17
Colorectal adenocarcinoma No 4 3 1.31
Prostate adenocarcinoma No 2 2 0.82
Bladder carcinoma No 3 2 2.04
Uterine corpus endometrioid carcinoma No 5 2 0.87
Multiple myeloma No 2 2 2.90
Breast carcinoma No 5 1 0.09
Lung squamous cell carcinoma No 2 1 0.57
Neuroblastoma No 1 1 0.48
Glioblastoma multiforme No 1 1 0.26
Esophageal carcinoma No 1 1 0.68
Lung adenocarcinoma No 2 0 0.00
Hepatocarcinoma No 3 0 0.00
Medulloblastoma No 1 0 0.00
Renal clear cell carcinoma No 2 0 0.00
Chronic lymphocytic leukemia No 2 0 0.00
Head and neck squamous cell carcinoma No 1 0 0.00
Diffuse B cell lymphoma No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence